The recent discovery that endothelial cells may be powerful regulators of tumors paves the way for a new approach to cancer treatment based on tissue engineering.

Roxane Laboratories has made labeling and product-packaging changes to its morphine sulfate oral solution 100 mg per 5 mL (20 mg/mL) due to accidental overdoses that resulted in adverse events and deaths.

A novel chemoradiation regimen for the treatment of anal cancer is proven to have fewer significant side effects than conventional therapy.

Amplicon fusion sites polymerase chain reaction (AFS-PCR) assay can detect and quantify human neuroblastoma cells in human blood and bone marrow samples.

A three-drug treatment for head and neck cancer (HNC) improves long-term survival so significantly that researchers are calling for the trio to become the standard of care for patients suitable for first-line therapy.

The Forum answers questions about desquamation under the breasts, Medicare guidelines for Procrit and Aranesp, hydration during cyclophosphamide, and ionized calcium and calcium level differences.

Data presented on the evolving role of radiation therapy in local and regional tumor control at the ASCO 2010 Breast Cancer Symposium, October 1-3, 2010, are reviewed.